Please login to the form below

Not currently logged in
Email:
Password:

Intellia

This page shows the latest Intellia news and features for those working in and with pharma, biotech and healthcare.

Vertex forges ties with gene editing firm CRISPR Therapeutics

Vertex forges ties with gene editing firm CRISPR Therapeutics

Celgene has also provided funding to CRISPR Thrapeutics, and earlier this year Novartis entered the fray after signing deals with Caribou Biosciences and Intellia Therapeutics that are focused on the development

Latest news

  • Novartis signs stem cell research pact with Intellia Novartis signs stem cell research pact with Intellia

    Novartis signs stem cell research pact with Intellia. Will work with the biotech start-up on creating new treatments. ... Intellia will gain access to certain Novartis intellectual property and technology for the development of its own product pipeline.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch May 2016 Deal Watch May 2016

    Earlier this month another CRISPR-Cas9 company, Intellia Therapeutics, raised $108m in an IPO to progress its early-stage programmes.

  • Deal Watch April 2016 Deal Watch April 2016

    265 . Intellia (US). Regeneron (US). Co-development &co-commercialisation. Discovery stage CRISPR/Cas platform for treatments of liver disease.

  • Deal Watch October 2015 Deal Watch October 2015

    companies. Other biotechs exploiting the CRISPR/Cas-9 technology for the development of therapeutics include Editas Medicine, Intellia Therapeutics and Caribou Biosciences; both Novartis and AstraZeneca have already developed collaborations in

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics